Search Results - "CRIGLER, J. F. JR"

Refine Results
  1. 1

    Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty by Mansfield, M J, Rudlin, C R, Crigler, Jr, J F, Karol, K A, Crawford, J D, Boepple, P A, Crowley, Jr, W F

    “…Suppression of gonadal sex steroid secretion in children with central precocious puberty (CPP) by LHRH analogs affords an opportunity to study sex steroid…”
    Get more information
    Journal Article
  2. 2

    Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls by Zachmann, M, Prader, A, Sobel, E H, Crigler, Jr, J F, Ritzén, E M, Atarés, M, Ferrandez, A

    Published in The Journal of pediatrics (01-05-1986)
    “…Spontaneous pubertal growth was studied in eight patients with the syndrome of androgen insensitivity to obtain information on the growth-promoting action of…”
    Get more information
    Journal Article
  3. 3
  4. 4

    The longitudinal study of adrenal maturation during gonadal suppression: Evidence that adrenarche is a gradual process by PALMERT, Mark R, HAYDEN, Douglas L, MANSFIELD, M. Joan, CRIGLER, John F, CROWLEY, William F, CHANDLER, Donald W, BOEPPLE, Paul A

    “…The physical changes that herald the onset of puberty result from the combination of adrenarche and gonadarche. To examine adrenal maturation and associated…”
    Get full text
    Journal Article
  5. 5

    Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche by WIERMAN, M. E, BEARDSWORTH, D. E, CRAWFORD, J. D, CRIGLER, J. F. JR, MANSFIELD, M. J, BODE, H. H, BOEPPLE, P. A, KUSHNER, D. C, CROWLEY, W. F. JR

    “…During puberty the effects of adrenal androgens upon skeletal maturation are obscured by the influence of gonadal steroids. Suppression of gonadarche with an…”
    Get full text
    Journal Article
  6. 6

    Puberty without gonadotropins. A unique mechanism of sexual development by Wierman, M E, Beardsworth, D E, Mansfield, M J, Badger, T M, Crawford, J D, Crigler, Jr, J F, Bode, H H, Loughlin, J S, Kushner, D C, Scully, R E

    Published in The New England journal of medicine (10-01-1985)
    “…Recent evidence suggests that a group of children exists in whom premature sexual maturation occurs in the absence of pubertal levels of gonadotropins; that…”
    Get more information
    Journal Article
  7. 7

    Impact of sex steroids and their suppression on skeletal growth and maturation by Boepple, P A, Mansfield, M J, Link, K, Crawford, J D, Crigler, Jr, J F, Kushner, D C, Blizzard, R M, Crowley, Jr, W F

    Published in The American journal of physiology (01-10-1988)
    “…Forty girls with central precocious puberty (CPP) were studied before and during 1-3 yr of luteinizing hormone-releasing factor (LHRH) agonist (LHRHa)…”
    Get full text
    Journal Article
  8. 8

    Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty by PALMERT, M. R, MANSFIELD, M. J, CROWLEY, W. F, CRIGLER, J. F, CRAWFORD, J. D, BOEPPLE, P. A

    “…Concern has been raised that children with central precocious puberty (CPP) are prone to the development of obesity. Here we report longitudinal height,…”
    Get full text
    Journal Article
  9. 9

    Detection of late-onset 21-hydroxylase deficiency congenital adrenal hyperplasia in adolescents by EMANS, S. J, GRACE, E, FLEISCHNICK, E, MANSFIELD, M. J, CRIGLER, J. F. JR

    Published in Pediatrics (Evanston) (01-11-1983)
    “…Because severe hirsutism is difficult to reverse, the evaluation of the adolescent girl with progressive hirsutism should aim at the pathophysiology of…”
    Get full text
    Journal Article
  10. 10

    Final height in estrogen-treated patients with Turner syndrome by Demetriou, E, Emans, S J, Crigler, Jr, J F

    Published in Obstetrics and gynecology (New York. 1953) (01-10-1984)
    “…The growth effects of estrogen therapy in 37 adolescent girls with gonadal dysgenesis associated with various X chromosomal abnormalities were investigated…”
    Get more information
    Journal Article
  11. 11

    Altered patterns of pituitary secretion and renal excretion of free alpha-subunit during gonadotropin-releasing hormone agonist-induced pituitary desensitization by Landy, H, Boepple, P A, Mansfield, M J, Whitcomb, R W, Schneyer, A L, Crawford, J D, Crigler, Jr, J F, Crowley, Jr, W F

    “…Intact LH and free alpha-subunit (FAS) are differentially regulated during GnRH agonist (GnRHa)-induced pituitary desensitization; circulating levels of FAS…”
    Get more information
    Journal Article
  12. 12

    Glycogen storage disease in adults by TALENTE, G. M, COLEMAN, R. A, HERMAN, G. E, ISSENMAN, R. M, KEATING, J. P, LINDE, R, ROE, T. F, SENIOR, B, WOLFSDORF, J. I, ALTER, C, BAKER, L, BROWN, B. I, CANNON, R. A, YONG-TSONG CHEN, CRIGLER, J. F, FERREIRA, P, HAWORTH, J. C

    Published in Annals of internal medicine (01-02-1994)
    “…To identify complications amenable to prevention in adults with glycogen storage disease (GSD) types Ia, Ib, and III and to determine the effect of the disease…”
    Get full text
    Journal Article
  13. 13

    Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease by Wolfsdorf, J.I, Crigler, J.F. Jr

    “…BACKGROUND:To evaluate the effects of continuous glucose therapy on metabolic control, occurrence of severe hypoglycemia, physical growth and development, and…”
    Get full text
    Journal Article
  14. 14

    Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease by Wolfsdorf, JI, Crigler, JF

    Published in The American journal of clinical nutrition (01-05-1997)
    “…The goal of treatment of type I glycogen storage disease (GSD-I) is to prevent hypoglycemia and its biochemical consequences. In seven patients with GSD-I with…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Metabolic control and renal dysfunction in type I glycogen storage disease by Wolfsdorf, J. I., Laffel, L. M. B., Crigler, J. F.

    Published in Journal of inherited metabolic disease (01-08-1997)
    “…This study was undertaken to determine the effect on renal function of continuous glucose therapy from early childhood. Twenty‐three subjects, median age 13.9…”
    Get full text
    Journal Article
  17. 17

    Thyrotropin-receptor autoantibodies in children and young adults with Graves' disease by Brown, R S, Kertiles, L P, Rosenfield, C, Kleinmann, R E, Crigler, Jr, J F

    “…Thyrotropin (TSH)-receptor autoantibodies were assessed by measurement of 125I-bTSH binding inhibition in 32 patients with juvenile-onset Graves' disease (one…”
    Get more information
    Journal Article
  18. 18

    Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty by Boepple, P A, Mansfield, M J, Wierman, M E, Rudlin, C R, Bode, H H, Crigler, Jr, J F, Crawford, J D, Crowley, Jr, W F

    Published in Endocrine reviews (01-02-1986)
    “…Studies utilizing the administration of GnRH in various GnRH-deficient models have revealed the critical importance of the dose and mode of delivery of this…”
    Get more information
    Journal Article
  19. 19

    Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease by Wolfsdorf, JI, Ehrlich, S, Landy, HS, Crigler, JF

    Published in The American journal of clinical nutrition (01-09-1992)
    “…To determine the optimal daytime dietary regimen for type 1 glycogen storage disease (GSD), we used uncooked cornstarch (UCS) at a basal glucose production…”
    Get full text
    Journal Article
  20. 20

    Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease by Wolfsdorf, J. I., Crigler, J. F.

    Published in Journal of inherited metabolic disease (01-03-1994)
    “…Summary To determine whether patients with GSD‐1 need nocturnal glucose therapy after completing physical growth and development, studies were performed on two…”
    Get full text
    Journal Article